Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Mirtazapine (6-Azamianserin) 是一种有效的具有口服活性的去甲肾上腺素能和特异性血清素能抗抑郁剂 (NaSSA)。它也是一种5-HT2、5-HT3、组胺 H1 受体和 α2-肾上腺素受体拮抗剂,pKi 值分别为 8.05、8.1、9.3 和 6.95。
规格 | 价格/CNY | 货期 | 数量 | |
---|---|---|---|---|
5 mg | ¥ 245 | 现货 | ||
10 mg | ¥ 348 | 现货 | ||
25 mg | ¥ 577 | 现货 | ||
50 mg | ¥ 856 | 现货 | ||
100 mg | ¥ 1,260 | 现货 | ||
200 mg | ¥ 1,930 | 现货 | ||
500 mg | ¥ 2,970 | 现货 | ||
1 mL * 10 mM (in DMSO) | ¥ 590 | 现货 |
产品描述 | Mirtazapine (6-Azamianserin) is a tetracyclic antidepressant with a somewhat unique mechanism of action. Mirtazapine therapy can be associated with transient asymptomatic elevations in serum aminotransferase levels and has been linked to rare instances of clinically apparent acute liver injury. |
体外活性 | Mirtazapine displays marked affinity for cloned, human alpha2A-adrenergic (AR) receptors at which it blocks noradrenaline (NA)-induced stimulation of guanosine-5'-O-(3-[35S]thio)-triphosphate ([35S]-GTPgammaS) binding. Mirtazapine shows high affinity for cloned, human serotonin (5-HT)2C receptors at which it abolishes 5-HT-induced phosphoinositide generation. Mirtazapine markedly elevates dialysate levels of NA and, in FCX, DA, whereas 5-HT is not affected.[1] Mirtazapine enhances the effectiveness of the electrical stimulation of the ascending 5-HT pathway by blocking both alpha-2 adrenergic auto- and heteroreceptors. Mirtazapine blocks the suppressant effect of microiontophoretically applied norepinephrine (NE) on the firing activity of CA3 dorsal hippocampus pyramidal neurons, indicating their antagonistic effects on postsynaptic alpha-2 adrenoceptors. [2] |
体内活性 | Mirtazapine (10-250 mg/kg i.v.) enhances dose-dependently the firing activity of the 5-HT neurons in naive rats, but not in 6-hydroxydopamine-pretreated rats. [2] Mirtazapine (5 mg/kg/day, s.c., using osmotic minipumps) increases the spontaneous firing activity of locus coeruleus noradrenaline (NA) neurons in male Sprague-Dawley rats. Mirtazapine antagonizes both the enhancing effect of a low dose (10 mg/kg, i.v.) and the reducing effect of a high dose (100 mg/kg, i.v.) of the alpha 2-adrenoceptor agonist clonidine on the effectiveness of the electrical stimulation of the ascending 5-HT pathway in suppressing the firing activity of dorsal hippocampus CA3 pyramidal neurons. [3] Mirtazapine (5 mg/kg s.c.) only slightly affects DOPAC and homovanillic acid levels in the striatum, hardly affects 5-HT release in freely moving rats, but clearly increased 5-hydroxyindole acetic acid. [4] |
别名 | 米氮平, 6-Azamianserin, Org3770 |
分子量 | 265.35 |
分子式 | C17H19N3 |
CAS No. | 85650-52-8 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Ethanol: 53 mg/mL (199.73 mM)
H2O: < 1 mg/mL (insoluble or slightly soluble)
DMSO: 53 mg/mL (199.73 mM)
可选溶剂 | 浓度 体积 质量 | 1 mg | 5 mg | 10 mg | 25 mg |
Ethanol / DMSO | 1 mM | 3.7686 mL | 18.843 mL | 37.6861 mL | 94.2152 mL |
5 mM | 0.7537 mL | 3.7686 mL | 7.5372 mL | 18.843 mL | |
10 mM | 0.3769 mL | 1.8843 mL | 3.7686 mL | 9.4215 mL | |
20 mM | 0.1884 mL | 0.9422 mL | 1.8843 mL | 4.7108 mL | |
50 mM | 0.0754 mL | 0.3769 mL | 0.7537 mL | 1.8843 mL | |
100 mM | 0.0377 mL | 0.1884 mL | 0.3769 mL | 0.9422 mL |
对于不同动物的给药剂量换算,您也可以参考 更多...
请在以下方框中输入您的动物实验信息后点击计算,可以得到母液配置方法和体内配方的制备方法: 比如您的给药剂量是10 mg/kg,每只动物体重20 g,给药体积100 μL,一共给药动物10 只,您使用的配方为5% DMSO+30% PEG300+5% Tween 80+60% ddH2O。那么您的工作液浓度为2 mg/mL。
母液配置方法:2 mg 药物溶于 50 μL DMSO (母液浓度为 40 mg/mL), 如您需要配置的浓度超过该产品的溶解度,请先与我们联系。
体内配方的制备方法:取 50 μL DMSO 主液,加入 300 μL PEG300, 混匀澄清,再加 50 μL Tween 80,混匀澄清,再加 600 μL ddH2O, 混匀澄清。
您可能有的问题的答案可以在抑制剂处理说明中找到,包括如何准备库存溶液,如何存储产品,以及基于细胞的分析和动物实验需要特别注意的问题。
Mirtazapine 85650-52-8 Endocrinology/Hormones GPCR/G Protein Immunology/Inflammation Neuroscience Dopamine Receptor 5-HT Receptor Opioid Receptor Adrenergic Receptor Histamine Receptor 米氮平 5-HT2 Inhibitor 5-HT3 α2-adrenoceptor inhibit oral serotonergic 5-hydroxytryptamine Receptor Antidepressant TNFα noradrenergic Org-3770 Beta Receptor 6-Azamianserin Org3770 Serotonin Receptor autoimmune Org 3770 inhibitor